Table 1.
Demographics of SLE patients, normal controls and disease controls*
| SLE patients (n = 40) | Normal controls (n = 30) | Disease controls (n = 18)+ | |
|---|---|---|---|
| Age, years | 33.48 ± 2.11 (14 to 70) | 29.23 ± 1.13 (19 to 42) | 38.39 ± 2.02 (18 to 54) |
| Female gender | 33 (82.5%) | 24 (80.0%) | 17 (94.1%) |
| Disease duration, years | 5.91 ± 0.94 (0.08 to 20) | ||
| SLEDAI score | 7.70 ± 0.90 (1 to 27) | ||
| Autoantibodies | |||
| Anti-dsDNA | 15 (37.5%) | ||
| Anti-Sm | 19 (47.5%) | ||
| Anti-SSA | 18 (45.0%) | ||
| Anti-SSB | 14 (35.0%) | ||
| Anti-U1RNP | 9 (22.5%) |
* Values are shown by mean ± SEM (range) or number (percentage). There were no significant differences between patients with systemic lupus erythematosus (SLE) and normal controls or disease controls in terms of age and gender.
+Consisted of 18 patients with rheumatoid arthritis. SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.